Streetbeat News

OLIT

OmniLit Acquisition Corp

Open

8.81

Mkt cap

52M

Volume

168K

High

9.49

P/E Ratio

-281.33

52-wk high

19.50

Low

7.80

Div yield

N/A

52-wk low

7.55

The article lists the stocks that gained and lost the most in Thursday's mid-day session. Some of the top gainers include OmniLit Acquisition Corp., Panbela Therapeutics, Inc., Lemonade, Inc., and Aware, Inc. due to positive news such as merger approvals, publication of clinical data, and strong quarterly results. On the other hand, Outlook Therapeutics, Inc., Confluent, Inc., Remitly Global, Inc., and Acurx Pharmaceuticals, Inc. were among the top losers due to negative news such as additional clinical trials required for approval, mixed financial results, and disappointing efficacy results from a Phase 2 trial.

Portfolio Pulse from Lisa Levin

November 02, 2023 | 6:26 pm

OmniLit Acquisition Corp. (OLIT) shares surged 200% in premarket trading after the company announced that its merger with Syntec was approved by shareholders.

Portfolio Pulse from Charles Gross

November 02, 2023 | 10:27 am

OmniLit Acquisition Corp. (OLIT) shareholders have approved the merger with Syntec Optics, Inc. Over 99.9% of the votes cast at the Annual Meeting were in favor of the business combination. OLIT plans to file the results with the SEC on a Form 8-K.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 7:15 pm

Syntec Optics, a provider of scientific and technical instruments and aerospace and defense optics, is set to list on Nasdaq via a merger with OmniLit. The company has been a pioneer in the manufacturing of scalable ultra-high precision optics for Low Earth Orbit (LEO) satellite systems. Syntec Optics is well-positioned to provide ultra-precision optics to enable the expanding market for satellites, which is projected by Morgan Stanley to reach $1 trillion by 2040.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 2:05 pm

OmniLit Acquisition Corp. (NASDAQ:OLIT) has announced that its registration statement on Form S-4, relating to the business combination with Syntec Optics, Inc., has been declared effective by the U.S. Securities and Exchange Commission. The Annual Meeting to approve the proposed business combination is scheduled to be held on October 31, 2023. If approved, the combined entity will commence trading on the Nasdaq under the new ticker symbols 'OPTX' and 'OPTXW'.

Portfolio Pulse from Benzinga Newsdesk

October 06, 2023 | 4:50 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.